Stefan D Baral1, Sosthenes Ketende, Sheree Schwartz, Ifeanyi Orazulike, Kelechi Ugoh, Sheila A Peel, Julie Ake, William Blattner, Manhattan Charurat. 1. *Key Populations Program, Center for Public Health and Human Rights, Department of Epidemiology, JHSPH, Baltimore, MD; †ICARH, Abuja, Nigeria; ‡Improving Men's Health Initiative, Abuja, Nigeria; §US Military HIV Research Project, Silver Spring, MD; ‖US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD; and ¶Division of Epidemiology and Prevention, Institute of Human Virology, University of Maryland, Baltimore, MD.
Abstract
INTRODUCTION: The TRUST model based on experimental and observational data posits that integration of HIV prevention and universal coverage of antiretroviral treatment at a trusted community venue provides a framework for achieving effective reduction in HIV-related morbidity and mortality among men who have sex with men (MSM) living with HIV, as well as reducing HIV incidence. The analyses presented here evaluate the utility of respondent-driven sampling as an implementation tool for engaging MSM in the TRUST intervention. METHODS: The TRUST integrated prevention and treatment model was established at a trusted community center serving MSM in Abuja, Nigeria. Five seeds have resulted in 3-26 waves of accrual between March 2013 and August 2014, with results presented here characterizing HIV burden and engagement in HIV care for 722 men across study recruitment waves. For analytic purposes, the waves were collapsed into 5 groups: 4 equally spaced (0-4, 5-9, 10-14, and 15-19) and 1 ranging from the 20th to the 26th wave with significance assessed using Pearson χ2 test. RESULTS: In earlier waves, MSM were more likely to have reported testing for HIV (82.9% in waves 0-4, 47.7% in waves 20-26; P < 0.01). In addition, biologically confirmed HIV prevalence decreased from an average of 59.1% to 42.9% (P < 0.05) in later waves. In earlier waves, about 80% of participants correctly reported their HIV status as compared with less than 25% in the later waves (P < 0.01). Finally, participants reporting being on ART decreased from 50% to 22.2% in later waves (P < 0.01). CONCLUSIONS: Implementation science studies focused on demonstrating impact of universal HIV treatment programs among people living with HIV necessitate different accrual methods than those focused on preventing HIV acquisition. Here, respondent-driven sampling was shown to be an efficient method for reaching marginalized populations of MSM living with HIV in Nigeria, and engaging them in universal HIV treatment services.
INTRODUCTION: The TRUST model based on experimental and observational data posits that integration of HIV prevention and universal coverage of antiretroviral treatment at a trusted community venue provides a framework for achieving effective reduction in HIV-related morbidity and mortality among men who have sex with men (MSM) living with HIV, as well as reducing HIV incidence. The analyses presented here evaluate the utility of respondent-driven sampling as an implementation tool for engaging MSM in the TRUST intervention. METHODS: The TRUST integrated prevention and treatment model was established at a trusted community center serving MSM in Abuja, Nigeria. Five seeds have resulted in 3-26 waves of accrual between March 2013 and August 2014, with results presented here characterizing HIV burden and engagement in HIV care for 722 men across study recruitment waves. For analytic purposes, the waves were collapsed into 5 groups: 4 equally spaced (0-4, 5-9, 10-14, and 15-19) and 1 ranging from the 20th to the 26th wave with significance assessed using Pearson χ2 test. RESULTS: In earlier waves, MSM were more likely to have reported testing for HIV (82.9% in waves 0-4, 47.7% in waves 20-26; P < 0.01). In addition, biologically confirmed HIV prevalence decreased from an average of 59.1% to 42.9% (P < 0.05) in later waves. In earlier waves, about 80% of participants correctly reported their HIV status as compared with less than 25% in the later waves (P < 0.01). Finally, participants reporting being on ART decreased from 50% to 22.2% in later waves (P < 0.01). CONCLUSIONS: Implementation science studies focused on demonstrating impact of universal HIV treatment programs among people living with HIV necessitate different accrual methods than those focused on preventing HIV acquisition. Here, respondent-driven sampling was shown to be an efficient method for reaching marginalized populations of MSM living with HIV in Nigeria, and engaging them in universal HIV treatment services.
Authors: Deborah Donnell; Jared M Baeten; James Kiarie; Katherine K Thomas; Wendy Stevens; Craig R Cohen; James McIntyre; Jairam R Lingappa; Connie Celum Journal: Lancet Date: 2010-05-26 Impact factor: 79.321
Authors: Chongyi Wei; Willi McFarland; Grant N Colfax; Vincent Fuqua; H Fisher Raymond Journal: Sex Transm Infect Date: 2012-06-29 Impact factor: 3.519
Authors: Kathryn E Muessig; M Kumi Smith; Kimberly A Powers; Ying-Ru Lo; David N Burns; Andrew E Grulich; Andrew N Phillips; Myron S Cohen Journal: AIDS Date: 2012-11-28 Impact factor: 4.177
Authors: Collins C Iwuji; Joanna Orne-Gliemann; Frank Tanser; Sylvie Boyer; Richard J Lessells; France Lert; John Imrie; Till Bärnighausen; Claire Rekacewicz; Brigitte Bazin; Marie-Louise Newell; François Dabis Journal: Trials Date: 2013-07-23 Impact factor: 2.279
Authors: Holly J Prudden; Charlotte H Watts; Peter Vickerman; Natalia Bobrova; Lori Heise; Michael K Ogungbemi; Amaka Momah; James F Blanchard; Anna M Foss Journal: AIDS Date: 2013-10-23 Impact factor: 4.177
Authors: Caitlin E Kennedy; Stefan D Baral; Rebecca Fielding-Miller; Darrin Adams; Phumlile Dludlu; Bheki Sithole; Virginia A Fonner; Zandile Mnisi; Deanna Kerrigan Journal: J Int AIDS Soc Date: 2013-12-02 Impact factor: 5.396
Authors: Cristina Rodriguez-Hart; Hongjie Liu; Rebecca G Nowak; Ifeanyi Orazulike; Sam Zorowitz; Trevor A Crowell; Stefan D Baral; William Blattner; Man Charurat Journal: AIDS Behav Date: 2016-11
Authors: Rebecca G Nowak; Andrew Mitchell; Trevor A Crowell; Hongjie Liu; Sosthenes Ketende; Habib O Ramadhani; Nicaise Ndembi; Sylvia Adebajo; Julie Ake; Nelson L Michael; William A Blattner; Stefan D Baral; Manhattan E Charurat Journal: J Acquir Immune Defic Syndr Date: 2019-04-01 Impact factor: 3.731
Authors: James Stannah; Elizabeth Dale; Jocelyn Elmes; Roisin Staunton; Chris Beyrer; Kate M Mitchell; Marie-Claude Boily Journal: Lancet HIV Date: 2019-10-07 Impact factor: 12.767
Authors: Shauna Stahlman; Rebecca G Nowak; Hongjie Liu; Trevor A Crowell; Sosthenes Ketende; William A Blattner; Manhattan E Charurat; Stefan D Baral Journal: AIDS Behav Date: 2017-11
Authors: Sheree R Schwartz; Rebecca G Nowak; Ifeanyi Orazulike; Babajide Keshinro; Julie Ake; Sara Kennedy; Ogbonnaya Njoku; William A Blattner; Manhattan E Charurat; Stefan D Baral Journal: Lancet HIV Date: 2015-07 Impact factor: 12.767
Authors: Nora E Rosenberg; Christopher C Stanley; Sarah E Rutstein; Naomi Bonongwe; Gift Kamanga; Audrey Pettifor; Clement Mapanje; Francis Martinson; Irving F Hoffman; William C Miller Journal: Sex Transm Infect Date: 2016-05-13 Impact factor: 3.519
Authors: Trevor A Crowell; Justin Hardick; Kara Lombardi; Zahra Parker; Afoke Kokogho; Senate Amusu; Sunday Odeyemi; Andrew Ivo; Stefan D Baral; Rebecca G Nowak; Sylvia Adebajo; Manhattan E Charurat; Julie Ake; Charlotte A Gaydos Journal: Sex Transm Infect Date: 2018-01-29 Impact factor: 3.519